Early Phase 1 Peripheral arterial occlusive disease Clinical Trials

2 recruitingEarly Phase 1

What is a Early Phase 1 trial?

Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.

Showing 1–2 of 2 trials

Recruiting

Early Phase 1

Impact of Nrf2 Activation on Macrovascular, Microvascular & Leg Function & Walking Capacity in Peripheral Artery Disease

Peripheral arterial occlusive diseasePeripheral Arterial DiseasePeripheral Vascular Diseases+1 more

University of Nebraska20 enrolled1 locationNCT06319339

Recruiting

Early Phase 1

Safety, Tolerability, and Biodistribution of [89Zr]Zr-DFO-APAC in Subjects With PAOD/CLI and Healthy Volunteers (Acronyms: 89Zr = Zirconium-89, DFO = Desferrioxamine, APAC = AntiPlatelet AntiCoagulant, PET/CT = Positron Emission Tomography/Computed Tomography)

Peripheral arterial occlusive diseaseCritical Limb Ischemia

Aplagon Oy10 enrolled1 locationNCT06204237